Skip to main content
2024 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Back

J. Joshua Smith, MD, PhD

Associate Attending
Memorial Sloan Kettering Cancer Center
MSKCC, Weill Cornell Medical College
New York, New York, United States

J. Joshua Smith, M.D., Ph.D. is an Associate Member on the Colorectal Service in the Department of Surgery at MSK. His objective as a surgeon and scientist is to uncover more precise treatments for each individual rectal and colon cancer patient. He actively cares for patients with rectal, colon, and anal cancer using modern surgical methods in a cutting-edge multidisciplinary setting in New York. He is the co-Chair of the GI Oncology portfolio for the Alliance for Clinical Trials in Oncology, the co-chair of the GI Surgery Committee for the Alliance for Clinical Trials in Oncology, and is a member of the NCI's Rectal Anal Task Force. He serves as the Chair and Primary Investigator for the Janus Rectal Cancer Trial, an NCI-approved Phase II trial investigating clinical complete response and nonoperative management (NOM) in patients with rectal cancer through the Alliance for Clinical Trials in Oncology, SWOG and NRG Oncology. He remains an active co-investigator for the paradigm-changing, randomized trial integrating NOM for selected patients with rectal cancer (NCT02008656 – The OPRA Trial). He leads an NCI-funded laboratory at MSK working to understand the molecular underpinnings of disease progression in patients with rectal cancer and to develop individualized disease models facilitating both effective research and precision treatment. Dr. Smith serves as a leader of Project 1 of the recently submitted Rectal Cancer SPORE grant at MSK that focuses on predicting complete responders to total neoadjuvant therapy using artificial intelligence. Dr. Smith is also the incoming PI of the MSK T32 Surgical Oncology Training Grant.

ORCID: 0000-0003-2538-5456
https://pubmed.ncbi.nlm.nih.gov/?cmd=search&term=smith+jj+and+vanderbilt+OR+smith,+j+joshua+and+memorial+sloan+kettering+

Disclosure information not submitted.

Presentation(s):

Email J. Joshua